Cancer News and Research

Latest Cancer News and Research

Phone counseling can help hazardous-drinking smokers quit smoking

Smokers who drink heavily have a tougher time quitting cigarettes than smokers who drink moderately or not at all. However, a multi-center study led by researchers in Yale Cancer Center and Yale School of Medicine found that modifying tobacco-oriented telephone counseling to help hazardous drinkers can help them quit smoking.

24 Nov 2014

Research: HD-IL2 can be effective in mRCC patients pre-treated with VEGF-targeted agents

High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated with VEGF-targeted agents, reveals research presented today at the ESMO Symposium on Immuno-Oncology in Geneva, Switzerland.

24 Nov 2014

Study: Adult survivors of retinoblastoma have few cognitive or social problems

Adult survivors of retinoblastoma, a type of eye cancer that usually develops in early childhood, have few cognitive or social problems decades following their diagnosis and treatment. That's the conclusion of a study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

24 Nov 2014

Study identifies H3.3 protein as key regulator in cellular senescence

Changes to the structure of the protein histone H3.3 may play a key role in silencing genes that regulate cancer cell growth, according to a study led by researchers from the Icahn School of Medicine at Mount Sinai and published online this month in the journal Nature Communications.

23 Nov 2014

Study highlights potential benefit of follow-up screening for woman with early breast cancer

Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health system perspective.

23 Nov 2014

20th annual edition of NCCN Guidelines for Prostate Cancer published

The National Comprehensive Cancer Network has published the 20th annual edition of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer—one of the eight original NCCN Guidelines published in November 1996.

23 Nov 2014

Higher Medicaid reimbursements for routine office visits linked to more cancer screening tests

Medicaid reimbursements for office visits to the doctor and for cancer screening tests vary substantially from state to state. New research in the journal Cancer finds that Medicaid recipients are more likely to receive cancer screening tests when their doctors receive higher reimbursements for routine office visits. In contrast, increased reimbursement rates for screening tests do not have a uniform effect on whether Medicaid beneficiaries get screened.

23 Nov 2014

Next-generation biomarker detects tumour cells, delivers anti-cancer drugs

Nanyang Technological University in Singapore has invented a unique biomarker with two exceptional functions.

23 Nov 2014

Researchers discover why only some patients respond to ipilimumab drug

A collaborative team of leaders in the field of cancer immunology from Memorial Sloan Kettering Cancer Center has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not. MSK was at the forefront of the clinical research that brought this CTLA-4 blocking antibody to melanoma patients.

23 Nov 2014

Research paves way for improving efficacy of ALS treatement

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a neurodegenerative disease that primarily kills motor neurons, leading to paralysis and death 2 to 5 years from diagnosis. Currently ALS has no cure. Despite promising early-stage research, the majority of drugs in development for ALS have failed. Now researchers have uncovered a possible explanation.

23 Nov 2014

Study provides estimates of obesity-attributable costs of absenteeism among U.S. workers

A study conducted by researchers at Columbia University's Mailman School of Public Health shows that obesity costs the U.S. $8.65 billion per year as a result of absenteeism in the workplace --more than 9% of all absenteeism costs.

23 Nov 2014

Research shows that immune checkpoint inhibitors may work in glioblastoma, brain metastases

New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.

23 Nov 2014

UCLA creates largest-ever protein that self-assembles into molecular 'cage'

UCLA biochemists have created the largest-ever protein that self-assembles into a molecular "cage." The research could lead to synthetic vaccines that protect people from the flu, HIV and other diseases.

23 Nov 2014

BIDMC's George Tsokos receives two prestigious awards at 2014 ACR Annual Scientific Meeting

George Tsokos, MD, Chief of Rheumatology at Beth Israel Deaconess Medical Center and a national leader in the field of lupus research was honored by both the Lupus Foundation of America and the American College of Rheumatology with two prestigious awards presented during the 2014 ACR Annual Scientific Meeting recently held in Boston.

23 Nov 2014

Researchers examine genomic landscapes of humans and mice

Looking across evolutionary time and the genomic landscapes of humans and mice, an international group of researchers has found powerful clues to why certain processes and systems in the mouse - such as the immune system, metabolism and stress response - are so different from those in people. Building on years of mouse and gene regulation studies, they have developed a resource that can help scientists better understand how similarities and differences between mice and humans are written in their genomes.

23 Nov 2014

Hydroxyurea therapy offers safe, effective disease management of SCA

Conclusive data show that hydroxyurea therapy offers safe and effective disease management of sickle cell anemia (SCA) and reduces the risk of stroke, prompting early termination by the National Heart Lung and Blood Institute of a key clinical trial studying the drug's efficacy.

23 Nov 2014

Endocrine Society issues Clinical Practice Guideline on rare bone condition

The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of Paget's disease of the bone, a condition where one or more bones in the body become oversized and weak.

23 Nov 2014

New drug shows promise against treatment-resistant non-small cell lung cancer

A new drug that targets not only common cancer-causing genetic mutations in patients with non-small cell lung cancer (NSCLC), but also a form of the mutation that causes resistance to treatment, has shown promising results in patients in a phase I/II clinical trial.

23 Nov 2014

Digoxin drug associated with higher risk of death, hospitalization among adults with atrial fibrillation

Digoxin, a drug commonly used to treat heart conditions, was associated with a 71 percent higher risk of death and a 63 percent higher risk of hospitalization among adults with diagnosed atrial fibrillation and no evidence of heart failure, according to a Kaiser Permanente study that appears in the current online issue of Circulation: Arrhythmia and Electrophysiology.

21 Nov 2014

2014 Canadian Prix Galien for Innovative Product Award presented to Esbriet (pirfenidone)

This year's prestigious Canadian Prix Galien for Innovative Product Award has been presented to Esbriet (pirfenidone), a medicine used to treat idiopathic pulmonary fibrosis (IPF). It is the only medication approved in Canada with a specific IPF indication and is approved for mild to moderate IPF in adults.

21 Nov 2014

Cancer News and Research

Latest Cancer News and Research

Phone counseling can help hazardous-drinking smokers quit smoking

Research: HD-IL2 can be effective in mRCC patients pre-treated with VEGF-targeted agents

Study: Adult survivors of retinoblastoma have few cognitive or social problems

Study identifies H3.3 protein as key regulator in cellular senescence

Study highlights potential benefit of follow-up screening for woman with early breast cancer

20th annual edition of NCCN Guidelines for Prostate Cancer published

Higher Medicaid reimbursements for routine office visits linked to more cancer screening tests

Next-generation biomarker detects tumour cells, delivers anti-cancer drugs

Researchers discover why only some patients respond to ipilimumab drug

Research paves way for improving efficacy of ALS treatement

Study provides estimates of obesity-attributable costs of absenteeism among U.S. workers

Research shows that immune checkpoint inhibitors may work in glioblastoma, brain metastases

UCLA creates largest-ever protein that self-assembles into molecular 'cage'

BIDMC's George Tsokos receives two prestigious awards at 2014 ACR Annual Scientific Meeting

Researchers examine genomic landscapes of humans and mice

Hydroxyurea therapy offers safe, effective disease management of SCA

Endocrine Society issues Clinical Practice Guideline on rare bone condition

New drug shows promise against treatment-resistant non-small cell lung cancer

Digoxin drug associated with higher risk of death, hospitalization among adults with atrial fibrillation

2014 Canadian Prix Galien for Innovative Product Award presented to Esbriet (pirfenidone)

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Newsletters you may be interested in